Massias L - Search Results

1

Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.

de Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, Massias L, Papy E, Tubach F, Wolff M, Sonneville R. de Montmollin E, et al. Among authors: massias l. Intensive Care Med. 2014 Jul;40(7):998-1005. doi: 10.1007/s00134-014-3276-x. Epub 2014 Apr 1. Intensive Care Med. 2014. PMID: 24687298

2

The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.

Quintard H, Papy E, Massias L, Lasocki S, Arnaud P, Desmonts JM, Montravers P. Quintard H, et al. Among authors: massias l. Ther Drug Monit. 2008 Feb;30(1):117-9. doi: 10.1097/FTD.0b013e31815c1672. Ther Drug Monit. 2008. PMID: 18223474

3

Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation.

Ruiz S, Papy E, Da Silva D, Nataf P, Massias L, Wolff M, Bouadma L. Ruiz S, et al. Among authors: massias l. Intensive Care Med. 2009 Jan;35(1):183-4. doi: 10.1007/s00134-008-1269-3. Epub 2008 Sep 16. Intensive Care Med. 2009. PMID: 18795256 No abstract available.

4

Very-high-dose caspofungin combined with voriconazole to treat central nervous system aspergillosis: substantial penetration of caspofungin into cerebrospinal fluid.

Réminiac F, Sonneville R, Massias L, Chochillon C, Wolff M. Réminiac F, et al. Among authors: massias l. Antimicrob Agents Chemother. 2014 Jun;58(6):3568-9. doi: 10.1128/AAC.02719-14. Epub 2014 Apr 14. Antimicrob Agents Chemother. 2014. PMID: 24733459 Free PMC article. No abstract available.

5

Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator-associated pneumonia and evaluation of dosage regimens.

Couffignal C, Pajot O, Laouénan C, Burdet C, Foucrier A, Wolff M, Armand-Lefevre L, Mentré F, Massias L. Couffignal C, et al. Among authors: massias l. Br J Clin Pharmacol. 2014 Nov;78(5):1022-34. doi: 10.1111/bcp.12435. Br J Clin Pharmacol. 2014. PMID: 24903189 Free PMC article. Clinical Trial.

6

Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia.

Burdet C, Pajot O, Couffignal C, Armand-Lefèvre L, Foucrier A, Laouénan C, Wolff M, Massias L, Mentré F. Burdet C, et al. Among authors: massias l. Eur J Clin Pharmacol. 2015 Jan;71(1):75-83. doi: 10.1007/s00228-014-1766-y. Epub 2014 Oct 21. Eur J Clin Pharmacol. 2015. PMID: 25327505 Free article. Clinical Trial.

7

Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia.

Pajot O, Burdet C, Couffignal C, Massias L, Armand-Lefevre L, Foucrier A, Da Silva D, Lasocki S, Laouénan C, Mentec H, Mentré F, Wolff M. Pajot O, et al. Among authors: massias l. J Antimicrob Chemother. 2015 May;70(5):1487-94. doi: 10.1093/jac/dku569. Epub 2015 Jan 27. J Antimicrob Chemother. 2015. PMID: 25630642

8

Outbreak of Pneumocystis jirovecii Infection Among Heart Transplant Recipients: Molecular Investigation and Management of an Interhuman Transmission.

Vindrios W, Argy N, Le Gal S, Lescure FX, Massias L, Le MP, Wolff M, Yazdanpanah Y, Nevez G, Houze S, Dorent R, Lucet JC. Vindrios W, et al. Among authors: massias l. Clin Infect Dis. 2017 Oct 1;65(7):1120-1126. doi: 10.1093/cid/cix495. Clin Infect Dis. 2017. PMID: 28549105

9

Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis.

Le Meur L, Tantet C, Lê MP, Desselas E, Bonnal C, Lillo-Le-Louet A, Sonneville R, Massias L, Giraud J, Descamps D, Yazdanpanah Y, Lariven S, Peytavin G. Le Meur L, et al. Among authors: massias l. J Antimicrob Chemother. 2018 Apr 1;73(4):1108-1110. doi: 10.1093/jac/dkx495. J Antimicrob Chemother. 2018. PMID: 29294026 No abstract available.

10

Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial.

Burdet C, Loubet P, Le Moing V, Vindrios W, Esposito-Farèse M, Linard M, Ferry T, Massias L, Tattevin P, Wolff M, Vandenesch F, Grall N, Quintin C, Mentré F, Duval X, Lescure FX; CloCeBa study group. Burdet C, et al. Among authors: massias l. BMJ Open. 2018 Sep 1;8(8):e023151. doi: 10.1136/bmjopen-2018-023151. BMJ Open. 2018. PMID: 30173161 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters